WisdomTree BioRevolution Fund (WDNA)

BATS: WDNA · Real-Time Price · USD

17.93

0.00 (-0.01%)

At close: Apr 9, 2026, 4:00 PM EDT

17.93

0.00 (0.00%)

After-hours: Apr 9, 2026, 8:00 PM EDT

-0.01% (1D)

Assets	$2.29M
Expense Ratio	0.45%
PE Ratio	21.41
Shares Out	130,000
Dividend (ttm)	$0.77
Dividend Yield	4.30%
Ex-Dividend Date	Dec 26, 2025
Payout Frequency	Annual
Payout Ratio	93.41%

Volume	10
Open	17.93
Previous Close	17.93
Day's Range	17.93 - 17.93
52-Week Low	11.24
52-Week High	18.88
Beta	1.06
Holdings	84
Inception Date	Jun 3, 2021

About WDNA

Fund Home Page

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is issued by WisdomTree.

Asset Class Equity

Category Health

Stock Exchange BATS

Ticker Symbol WDNA

ETF Provider WisdomTree

Index Tracked WisdomTree BioRevolution Index

Top 10 Holdings

27.55% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	4.32%
Johnson & Johnson	JNJ	3.08%
Pfizer Inc.	PFE	2.69%
Eli Lilly and Company	LLY	2.64%
United Therapeutics Corporation	UTHR	2.62%
Natera, Inc.	NTRA	2.56%
Stoke Therapeutics, Inc.	STOK	2.52%
Twist Bioscience Corporation	TWST	2.47%
Structure Therapeutics Inc.	GPCR	2.34%
AstraZeneca PLC	AZN	2.32%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 26, 2025	$0.77052	Dec 30, 2025
Dec 26, 2024	$0.1071	Dec 30, 2024
Dec 22, 2023	$0.135	Dec 28, 2023
Dec 23, 2022	$0.06526	Dec 29, 2022
Dec 27, 2021	$0.02458	Dec 30, 2021

Full Dividend History

Performance

WDNA had a total return of 66.24% in the past year, including dividends. Since the fund's inception, the average annual return has been -5.31%.